Philip Morris considers selling stake in pharmaceuticals unit to boost healthcare division

The company's wellness division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.